A detailed history of Eagle Rock Investment Company, LLC transactions in Compugen LTD stock. As of the latest transaction made, Eagle Rock Investment Company, LLC holds 70,000 shares of CGEN stock, worth $98,700. This represents 0.02% of its overall portfolio holdings.

Number of Shares
70,000
Previous 70,000 -0.0%
Holding current value
$98,700
Previous $117,000 7.69%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 25, 2023

BUY
$0.58 - $1.2 $20,300 - $42,000
35,000 Added 100.0%
70,000 $0
Q2 2022

Aug 12, 2022

BUY
$1.57 - $3.33 $27,475 - $58,275
17,500 Added 100.0%
35,000 $65,000
Q1 2022

May 11, 2022

SELL
$2.76 - $4.64 $5,045 - $8,481
-1,828 Reduced 9.46%
17,500 $56,000
Q4 2021

Feb 17, 2022

BUY
$4.09 - $7.16 $79,051 - $138,388
19,328 New
19,328 $83,000

Others Institutions Holding CGEN

About COMPUGEN LTD


  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $122M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Eagle Rock Investment Company, LLC Portfolio

Follow Eagle Rock Investment Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Rock Investment Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Rock Investment Company, LLC with notifications on news.